Skip to main content

Table 1 Recipients' characteristics

From: Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis

  All patients n = 124 Bronchiectasis n = 13 Non-bronchiectasis n = 111 p value
Age at LTX, median (IQR) 45 (34–51) 50 (44.5–53.5) 43 (33–50) 0.062
Male, n (%) 48 (38.7%) 7 (53.8%) 41 (36.9%) 0.247
LTX procedure, n (%)      < 0.0001
 Cadaveric single 67 (54.0%) 0 (0.0%) 67 (60.4%)  
 Cadaveric bilateral 48 (38.7%) 12 (92.3%) 36 (32.4%)  
 Living-donor 9 (7.3%) 1 (7.7%) 8 (7.2%)  
LTX indication category, n (%)     N/A
 Suppurative lung disease 13 (10.5%) 13 (100%)   
 Restrictive lung disease 30 (24.2%)   30 (27.0%)  
 Pulmonary vascular disease 27 (21.8%)   27 (24.3%)  
 Obstructive lung disease 51 (39.5%)   51 (49.9%)  
 Others 3 (2.4%)   3 (2.7%)  
Chronic sinusitis, n (%) 19 (15.3%) 10 (76.9%) 9 (8.1%)  < 0.0001
Connective tissue disease, n (%) 14 (11.3%) 2 (15.4%) 12 (10.8%) 0.641
Gastroesophageal reflux disease, n (%) 10 (8.1%) 2 (15.4%) 8 (7.2%) 0.282
Diabetes 8 (6.5%) 0 (0.0%) 8 (7.2%) 0.999
Underweight (BMI < 18.5 kg/m2), n (%) 67 (54.0%) 6 (46.2%) 61 (55.0%) 0.571
History of Pseudomonas colonization, n (%) 13 (10.5%) 12 (92.3%) 1 (0.9%)  < 0.0001
History of NTM isolation, n (%) 5 (4.0%) 1 (7.7%) 4 (3.6%) 0.431
Ischemic time (min), median (IQR) 502 (431–666) 685 (635–734) 493 (429–643) 0.002
CMV mismatch, n (%) 21 (16.9%) 1 (8.3%) 20 (18%) 0.689
  1. LTX, lung transplant; IQR, interquartile range; BMI, body-mass index; NTM, non-tuberculous mycobacterium; CMV, cytomegalovirus; N/A, not applicable